Please provide your email address to receive an email when new articles are posted on . Vancomycin, the only available glycopeptide antibiotic in the United States, continues to be a mainstay of ...
Jennifer Le, PharmD Pediatric patients who attain higher trough levels of the drug may be at higher risk of kidney damage. SAN FRANCISCO—Nephrotoxicity from vancomycin therapy develops more quickly in ...
August 25, 2008 — Lower minimal inhibitory concentrations (MICs) than the US Food and Drug Administration (FDA) has used as breakpoints may predict vancomycin treatment failure against ...
Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results